Skip to main content
Clinical Trials/NCT04808336
NCT04808336
Completed
Not Applicable

Platelet Rich Plasma Injection Versus Surgical Fixation Procedure in Management of Spondylolisthesis grade1.

Menoufia University1 site in 1 country60 target enrollmentMarch 26, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Degenerative Spondylolisthesis G1
Sponsor
Menoufia University
Enrollment
60
Locations
1
Primary Endpoint
1-Visual analogue scale. ,
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Spondylolisthesis is a serious health condition that is often treated with surgery or pain-relieving lumbar epidural steroids. Patients with persistent and debilitating symptoms who have failed to respond to conservative treatment should consider surgery.

Objectives: The aim of this study was to compare the therapeutic efficacy of three ultrasound guided PRP injections of the facet joint capsule to surgical procedures in patients with degenerative spondylolisthesis G1 and their effect on neurogenic pain relief and functional improvement over a one-year follow-up period.

Methods:

A one-year prospective randomised comparative clinical trial was performed on 60 patients with degenerative spondylolisthesis G1 who were randomly assigned to one of two groups: Group 1: thirty patients were injected in the facet joint capsule with a series of three ultrasound-guided PRP injections at four-week intervals, and Group 2: thirty patients underwent surgery. They were exposed to clinical neuropsychological testing.They were assessed for pain and function using clinical neurological assessments, VAS (Visual Analogue Scale), FRI (Functional Rating Index), Roland Morris, and ODI.

Registry
clinicaltrials.gov
Start Date
March 26, 2019
End Date
May 26, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dalia Salah Saif

lecturer of Rheumatology at faculty of medicine Menoufia University

Menoufia University

Eligibility Criteria

Inclusion Criteria

  • Patients with degenerative spondylolithesis Grade 1 were diagnosed based on their clinical and radiological image.
  • Patients complained of extreme pain and received medical treatment (NSAIDS) without improvement.

Exclusion Criteria

  • Patients with more than two-level pathological lesions and those who had previously
  • Patients undergone lumbar surgery,
  • HCV, HBV infected patients,
  • patients with local abscesses,
  • diabetes mellitus,
  • malignancy, pregnancy,
  • blood disorders (coagulopathy, thrombocytopenia),
  • patients who had previously received local injection of steroid within past 3 weeks
  • Patients who had undergone lumbar surgery,
  • patients with advanced spondylolithesis, disc prolapse,

Outcomes

Primary Outcomes

1-Visual analogue scale. ,

Time Frame: 12 months

VAS Visual analogue scale: According to the VAS, the pain severity was calculated by the patients on a scale of 0 (no pain) to 10 (agonising pain)

2-The Persian Functional Rating Index (FRI )

Time Frame: 12 months

The Persian Functional Rating Index (FRI ), which is an accurate and valid instrument that contains 10 items that measure both pain and function, with an impairment score ranging from 0% (no disability) to 100% (severe disability) 2- The Persian Functional Rating Index (FRI ), which is an accurate and valid instrument that contains 10 items that measure both pain and function, with an impairment score ranging from 0% (no disability) to 100% (severe disability)

Secondary Outcomes

  • Oswestry Disability Index (ODI) for low back pain(12 months)
  • The Roland-Morris questionnaire(12 months)

Study Sites (1)

Loading locations...

Similar Trials